|
VPS8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.78530000022926E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.969600E-04 |
| Normal-vs-Stage2 |
2.227500E-02 |
| Normal-vs-Stage3 |
3.845400E-01 |
| Normal-vs-Stage4 |
2.447200E-01 |
| Stage1-vs-Stage2 |
2.039600E-01 |
| Stage1-vs-Stage3 |
2.222000E-01 |
| Stage1-vs-Stage4 |
4.419700E-02 |
| Stage2-vs-Stage3 |
8.252000E-02 |
| Stage2-vs-Stage4 |
1.120180E-02 |
| Stage3-vs-Stage4 |
2.243800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53322999999483E-05 |
| Normal-vs-AfricanAmerican |
7.879800E-03 |
| Normal-vs-Asian |
8.381600E-02 |
| Caucasian-vs-AfricanAmerican |
6.462200E-01 |
| Caucasian-vs-Asian |
2.939600E-01 |
| AfricanAmerican-vs-Asian |
2.556400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.69860000000166E-05 |
| Normal-vs-Female |
1.74759999999052E-05 |
| Male-vs-Female |
6.605500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.083700E-02 |
| Normal-vs-Extreme_Weight |
7.223300E-03 |
| Normal-vs-Obese |
4.958000E-03 |
| Normal-vs-Extreme_Obese |
9.137600E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.052200E-01 |
| Normal_Weight-vs-Obese |
4.946000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.972400E-01 |
| Extreme_Weight-vs-Obese |
5.489200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.630400E-01 |
| Obese-vs-Extreme_Obese |
4.904200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.163500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.53390000035003E-07 |
| Normal-vs-Age(61-80Yrs) |
5.963000E-04 |
| Normal-vs-Age(81-100Yrs) |
9.235000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.784200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.811000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.277760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.013700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.885900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.967810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.94060006847496E-10 |
| Normal-VS-Type2 PRCC |
4.907800E-01 |
| Normal-VS-KIRP CIMP |
6.140000E-01 |
| Normal-VS-Unclassified PRCC |
1.226050E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.87720000002878E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.561260E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.496600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.410200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.244200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.113880E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.335640E-01 |
| Normal-vs-N1 |
1.170600E-01 |
| Normal-vs-N2 |
7.672000E-01 |
| N0-vs-N1 |
6.923600E-01 |
| N0-vs-N2 |
3.788400E-01 |
| N1-vs-N2 |
3.120600E-01 |
|
|
